Akèy › Kolit Ulseratif › North Carolina
Etid klinik pou Kolit Ulseratif nan North Carolina
24 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Charlotte Gastroenterology and Hepatology, P.L.L.C, Charlotte
- Carolina Digestive Diseases, Greenville
- Piedmont Healthcare, Statesville
- ak 1 plis
Ap rekriteFaz 4
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943Confirmatory Clinical Study in Active Ulcerative Colitis
- Cross Creek Medical Clinic, Fayetteville
- Peters Medical Research, High Point
Ap rekriteFaz 2
Laj 16 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07296315A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- 040, Chapel Hill
- Site 041, Durham
- Site 016, Winston-Salem
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Raleigh
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Partners /ID# 280490, Asheville
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07697456A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Monroe Biomedical Research, Monroe
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Coastal Research Institute - Fayetteville, Fayetteville
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Carolina Digestive Diseases and Endoscopy Center, Greenville
- Wilmington Health, PLLC, Wilmington
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Partners, Asheville
- University of North Carolina, Chapel Hill
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Cross Creek Medical Clinic - Site Number: 8400057, Fayetteville
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Aug 28, 2026 · NCT07654751A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Atrium Health Gastroenterology and Hepatology, Charlotte
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 21, 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- UNC Hospitals, The University of North Carolina at Chapel Hill - Site Number: 8400074, Chapel Hill
- OnSite Clinical Solutions - Site Number: 8400051, Charlotte
- Duke University Medical Center - Site Number: 8400093, Durham
- ak 3 plis
Ap rekriteFaz 3
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- UNC Chapel Hill, Chapel Hill
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of North Carolina, Chapel Hill
- Atrium Health Center for Gastroenterology and Surgery, Charlotte
- Wake Forest School of Medicine, Winston-Salem
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill
- OnSite Clinical Solutions, LLC, Charlotte
Ap rekriteEtid obsèvasyon
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
- PPD Virtual - PPD - US, Wilmington
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Jun 15, 2026 · NCT05953402A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400002, Chapel Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Apr 23, 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, High Point
- Mirador Therapeutics Selected Site, Raleigh
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 010, Greenville
Ap rekriteFaz 4
Laj 5 a 17 · Tout sèks · Mizajou Sep 16, 2025 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- University of North Carolina, Chapel Hill
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2025 · NCT06750731IBD Pregnancy Registry
- PPD, Wilmington
Ap rekriteEtid obsèvasyon
Laj 18 a 50 · Fanm · Mizajou Apr 4, 2025 · NCT06910553Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.